Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
18 Cards in this Set
- Front
- Back
- 3rd side (hint)
Glycopyrrolate (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - IV; quartenary amine
|
|
Glycopyrrolate (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Mepenzolate (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO; quartenary amine
|
|
Mepenzolate (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Methscopolamine (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO; quartenary amine
|
|
Methscopolamine (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Tridihexethyl (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO; quartenary amine
|
|
Tridihexethyl (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Clindinium (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO; quartenary amine
|
|
Clindinium (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Trospium (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO/PR/IV; quartenary amine
|
|
Trospium (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Propantheline (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - PO; quartenary amine
|
|
Propantheline (CU & T)
|
CU - IBS; minor diarrhea; block muscarinic effects in periphery
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Ipratropium (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - Inhaled; quartenary amine
|
|
Ipratropium (CU & T)
|
CU - Asthma and COPD
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|
|
Tiotropium (MOA & PK)
|
MOA - Reversibly inhibits ACh binding to muscarinic receptors
|
PK - Inhaled; longer duration than ipratropium; quartenary amine
|
|
Tiotropium (CU & T)
|
CU - Asthma and COPD
|
T - Decreased sweating and lacrimation, elevation of body temp, tachycardia, constipation, dry mouth, and blurred vision+ mydriasis, sedation, amnesia, delirium or hallucinations, heart arrhythmias, cutaneous vasodilation; reduced CNS effects
|